» Authors » Sandy DeVries

Sandy DeVries

Explore the profile of Sandy DeVries including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 3309
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Tward J, Huang H, Esteva A, Mohamad O, van der Wal D, Simko J, et al.
JCO Precis Oncol . 2024 Oct; 8:e2400145. PMID: 39447096
Purpose: Current clinical risk stratification methods for localized prostate cancer are suboptimal, leading to over- and undertreatment. Recently, machine learning approaches using digital histopathology have shown superior prognostic ability in...
2.
Spratt D, Tang S, Sun Y, Huang H, Chen E, Mohamad O, et al.
NEJM Evid . 2024 Feb; 2(8):EVIDoa2300023. PMID: 38320143
BACKGROUND: Androgen deprivation therapy (ADT) with radiotherapy can benefit patients with localized prostate cancer. However, ADT can negatively impact quality of life, and there remain no validated predictive models to...
3.
Ross A, Zhang J, Huang H, Yamashita R, Keim-Malpass J, Simko J, et al.
Eur Urol Oncol . 2024 Feb; 7(5):1024-1033. PMID: 38302323
Background: Accurate risk stratification is critical to guide management decisions in localized prostate cancer (PCa). Previously, we had developed and validated a multimodal artificial intelligence (MMAI) model generated from digital...
4.
Spratt D, Tang S, Sun Y, Huang H, Chen E, Mohamad O, et al.
Res Sq . 2023 May; PMID: 37131691
Background: Androgen deprivation therapy (ADT) with radiotherapy can benefit patients with localized prostate cancer. However, ADT can negatively impact quality of life and there remain no validated predictive models to...
5.
Esteva A, Feng J, van der Wal D, Huang S, Simko J, DeVries S, et al.
NPJ Digit Med . 2023 Feb; 6(1):27. PMID: 36813827
No abstract available.
6.
Esteva A, Feng J, van der Wal D, Huang S, Simko J, DeVries S, et al.
NPJ Digit Med . 2022 Jun; 5(1):71. PMID: 35676445
Prostate cancer is the most frequent cancer in men and a leading cause of cancer death. Determining a patient's optimal therapy is a challenge, where oncologists must select a therapy...
7.
Lal A, Chan L, DeVries S, Chin K, Scott G, Benz C, et al.
Breast Cancer Res Treat . 2013 May; 139(2):381-90. PMID: 23712790
FOXP3-expressing T regulatory lymphocytes (Tregs) have been described as putative mediators of immune tolerance, and thus facilitators of tumor growth. When found in association with various malignancies, Tregs are generally...
8.
Hwang E, Lal A, Chen Y, DeVries S, Swain R, Anderson J, et al.
Hum Pathol . 2011 Apr; 42(10):1467-75. PMID: 21496874
A clinically distinct subgroup of pure ductal carcinoma in situ presents as an extensive, high-grade lesion, which nevertheless lacks invasion. We sought to evaluate differences between those ductal carcinomas in...
9.
Horvai A, DeVries S, Roy R, ODonnell R, Waldman F
Mod Pathol . 2009 Sep; 22(11):1477-88. PMID: 19734852
Liposarcoma represents a unique model insofar as some well-differentiated liposarcomas progress to non-lipogenic, so-called 'dedifferentiated,' forms. The well-differentiated and dedifferentiated family of liposarcomas demonstrates amplification of the chromosome subregion 12q13-q15...
10.
Chen Y, Hwang E, Roy R, DeVries S, Anderson J, Wa C, et al.
Am J Surg Pathol . 2009 Aug; 33(11):1683-94. PMID: 19701073
The clinical, pathologic, and molecular features of pleomorphic lobular carcinoma in situ (PLCIS) and the relationship of PLCIS to classic LCIS (CLCIS) are poorly defined. In this study, we analyzed...